Literature DB >> 18778783

Assessment of drug induced developmental toxicity using human embryonic stem cells.

Ashish Mehta1, Vijay Bhaskar R Konala, Aparna Khanna, Anish S Majumdar.   

Abstract

Embryonic stem (ES) cells are unique as they have the potential to be generated in large numbers and the ability to differentiate into the three germ layers via embryoid body (EB) formation. This property could be utilized as an index to study initial mammalian development. We have investigated the utility of a comprehensively characterized human ES (hES) cell line (ReliCellhES1) for testing the embryotoxic effects of compounds using cytotoxicity assays. Further, we performed real time gene expression analysis to check the alterations in germ layer markers expression upon drug treatment. The results show that assays using hES cells could serve as a reliable, sensitive and robust method to assess embryotoxic potential of compounds. They also provide a proof of concept that hES cells can be used as an in vitro model to demonstrate developmental toxicity, and to examine the germ layer-specific effects on differentiating EBs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778783     DOI: 10.1016/j.cellbi.2008.08.012

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  14 in total

Review 1.  Alternative models in developmental toxicology.

Authors:  Hyung-yul Lee; Amy L Inselman; Jyotshnabala Kanungo; Deborah K Hansen
Journal:  Syst Biol Reprod Med       Date:  2012-02       Impact factor: 3.061

Review 2.  Teratogen screening with human pluripotent stem cells.

Authors:  Kathryn E Worley; Jennifer Rico-Varela; Dominic Ho; Leo Q Wan
Journal:  Integr Biol (Camb)       Date:  2018-09-17       Impact factor: 2.192

Review 3.  Present state and future perspectives of using pluripotent stem cells in toxicology research.

Authors:  Anna M Wobus; Peter Löser
Journal:  Arch Toxicol       Date:  2011-01-12       Impact factor: 5.153

4.  Wnt/β-Catenin and MEK-ERK Signaling are Required for Fibroblast-Derived Extracellular Matrix-Mediated Endoderm Differentiation of Embryonic Stem Cells.

Authors:  Kevin Dzobo; Matjaz Vogelsang; M Iqbal Parker
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

5.  Gene-modified embryonic stem cell test to characterize chemical risks.

Authors:  Kohei Kitada; Akane Kizu; Takeshi Teramura; Toshiyuki Takehara; Masami Hayashi; Daisuke Tachibana; Hideki Wanibuchi; Shoji Fukushima; Masayasu Koyama; Kayo Yoshida; Takashi Morita
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-24       Impact factor: 4.223

6.  BMP-2/6 heterodimer is more effective than BMP-2 or BMP-6 homodimers as inductor of differentiation of human embryonic stem cells.

Authors:  Elvira Valera; Michael J Isaacs; Yasuhiko Kawakami; Juan Carlos Izpisúa Belmonte; Senyon Choe
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

7.  Exposure-based assessment of chemical teratogenicity using morphogenetic aggregates of human embryonic stem cells.

Authors:  Yusuke Marikawa; Hong-Ru Chen; Mark Menor; Youping Deng; Vernadeth B Alarcon
Journal:  Reprod Toxicol       Date:  2019-11-08       Impact factor: 3.143

8.  Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells.

Authors:  Yoav Mayshar; Ofra Yanuka; Nissim Benvenisty
Journal:  J Cell Mol Med       Date:  2010-06-17       Impact factor: 5.310

9.  A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells.

Authors:  Ashish Mehta; Vinod Verma; Manasi Nandihalli; Chrishan J A Ramachandra; Glen L Sequiera; Yuliansa Sudibyo; Yingying Chung; William Sun; Winston Shim
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

Review 10.  Assessment of Developmental Toxicants using Human Embryonic Stem Cells.

Authors:  Eui-Ju Hong; Eui-Bae Jeung
Journal:  Toxicol Res       Date:  2013-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.